Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 17.797\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) CC(C)(C)c1ccc(-c2noc(CCC(=O)Nc3cccnc3)n2)cc1
b) C=CCc1ccc(OC(=O)c2ccccc2)c(OC)c1
c) O=C(NCc1ccccc1)C(=O)NCC1COc2ccccc2O1
d) CC(C)Sc1nc2ccccc2n1CC(N)=O
e) COc1ccc(Nc2ncnc3sc(-c4ccccc4)cc23)cc1
Answer: a. CC(C)(C)c1ccc(-c2noc(CCC(=O)Nc3cccnc3)n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)(C)c1ccc(-c2noc(CCC(=O)Nc3cccnc3)n2)cc1
CC(C)(C)c1ccc(-c2noc(CCC(=O)Nc3cccnc3)n2)cc1
3-[3-(4-tert-butylphenyl)-1,2,4-oxadiazol-5-yl]-N-pyridin-3-ylpropanamide